Complex Multigenic Disorders

Slide 1 · Complex Multigenic

Disorders

Inherited susceptibility • environmental influences • common disease

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning objectives

Distinguish monogenic, complex multigenic, and chromosomal genetic disease.

Explain common-variant susceptibility, risk haplotypes, and gene–environment interaction.

Interpret quantitative traits, disease examples, and GWAS findings critically.

Recognize why disease severity and GWAS signals alone do not establish clinical prediction.

Slide 3 · Common disease extends beyond Mendelian genetics

Monogenic

Large functional effect at a single gene

May show recognizable Mendelian inheritance

Reduced penetrance is still possible

Complex multigenic

Several susceptibility loci contribute

Environmental factors commonly matter

Each risk haplotype usually has a small effect

Single-gene disorders may follow recognizable dominant, recessive, or X-linked patterns.

Complex disorders involve multiple inherited genetic variants plus environment.

Slide 4 · Definition: Multifactorial inheritance

Inherited variant combinations

Environmental influences

Phenotype / disease susceptibility

Complex multigenic disorders reflect interactions among variant alleles at multiple loci.

Environmental influences contribute to disease susceptibility or expression.

Consequently, inheriting an associated variant does not imply inevitable disease.

Slide 5 · Polygenic describes the genetic architecture

Polygenic: More than one genetic locus contributes to the phenotype.

No single susceptibility allele ordinarily accounts for the total risk.

Contributions differ in magnitude across loci.

The overall genetic predisposition arises from their combined effects.

Slide 6 · Multifactorial includes the environment

Inherited component

Common variants

Risk haplotypes

Relative effects of loci

Environmental component

Diet

Physical activity

Nutrition and other contextual factors

Multifactorial: Genetic influences occur alongside non-genetic exposures.

The same genetic predisposition can yield different phenotypic expression in differing contexts.

Slide 7 · A polymorphism is a frequency-defined variant

≥1%

Population-frequency threshold

A polymorphism as a gene variant with population frequency of at least 1%.

The definition concerns population frequency; It does not establish pathogenicity.

Common polymorphisms can be components of disease susceptibility.

Slide 8 · Common does not mean disease-causing

A frequent allele may have little measurable effect on a given disease.

A risk-associated polymorphism often changes probability rather than determining the outcome.

Interpret a variant together with other inherited factors and the environment.

Slide 9 · Common disease/common variant hypothesis

Inherited variant combinations

Environmental influences

Phenotype / disease susceptibility

The CD/CV hypothesis connects frequent diseases with combinations of common alleles.

Each susceptibility allele is usually of modest effect and low penetrance.

Coinheritance plus interaction among variants and environmental factors promotes risk.

Slide 10 · Low penetrance: Susceptibility is not certainty

Penetrance is the probability that a genotype is expressed as a phenotype.

A small-effect variant may be carried by individuals who never develop the disease.

Low penetrance helps explain why a risk allele is not a stand-alone diagnosis.

Slide 11 · Risk contributions are unequal

Relatively larger contribution

A subset of major loci

Still probabilistic rather than fully penetrant

Relatively smaller contributions

Many additional loci

Collective inheritance remains relevant

Some associated loci contribute more to susceptibility than others.

The aggregate result is not adequately described by counting loci alone.

Slide 12 · Risk haplotypes identify inherited regions

Nearby variants

Inherited haplotype

Statistical association

Candidate region

Nearby polymorphisms can be inherited together as a haplotype.

An associated haplotype can track inherited susceptibility.

Association with a haplotype does not alone specify which sequence change is mechanistically responsible.

Slide 13 · Haplotype association is not gene identification

What an association shows

A marker correlates with disease status

A locus may harbor risk determinants

What remains unresolved

Exact functional variant

Causal gene and mechanism

Clinical usefulness for one person

An associated genomic region may contain multiple plausible genes or variants.

The statistical signal provides a starting point for investigating pathogenesis.

Slide 14 · Combined inheritance shapes susceptibility

Inherited variant combinations

Environmental influences

Phenotype / disease susceptibility

Several susceptibility haplotypes may be inherited in the same individual.

No single haplotype necessarily has a decisive effect.

Their combined contribution is modified by environmental influences.

Slide 15 · Sporadic disease can have a hereditary component

A disorder may occur without an obvious Mendelian pedigree.

A background of common alleles can still contribute to susceptibility.

An apparently sporadic case does not establish an absence of inherited risk.

Slide 16 · Disease risk is not fixed at conception

Relatively fixed

Inherited allele combinations

Risk-haplotype background

Potentially modifiable

Dietary pattern

Physical activity

Nutritional exposure

Inherited susceptibility is present before many environmental exposures.

Environmental factors can increase or decrease expression of some complex phenotypes.

Slide 17 · Why one variant rarely explains a common disorder

Several variants can contribute simultaneously.

Each associated haplotype may change odds only modestly.

Environmental variation adds another dimension of heterogeneity.

A single positive genotype is usually insufficient to identify who becomes ill.

Slide 18 · Shared biology can produce shared susceptibility

Autoimmune disorder A

Autoimmune disorder B

Shared risk variants

Some polymorphisms contribute to more than one disease of a related type.

Shared genetic signals among autoimmune disorders.

Overlapping loci imply partial, not complete, overlap in susceptibility architecture.

Slide 19 · Disease-specific variants preserve distinctions

Specific to A

Specific to B

Shared variants

Other susceptibility polymorphisms are associated preferentially with one disorder.

Both shared and disease-specific signals can coexist across diseases.

Similarity in genetic association does not make two clinical disorders identical.

Slide 20 · A useful model of complex disease

Inherited variant combinations

Environmental influences

Phenotype / disease susceptibility

A susceptibility phenotype can be viewed as the joint consequence of inherited variation and exposure.

Such a model illustrates relationships; It is not an individual risk calculator.

Do not assign numerical weights without empirically established data.

Slide 21 · Type 1 diabetes: An illustrative architecture

Many implicated loci

Several risk-associated regions

Distributed inherited susceptibility

Subset with greater impact

A few stronger contributors

HLA alleles are prominent

Type 1 diabetes to show that multiple genes contribute to risk.

It describes approximately 20–30 implicated genes, with about 6–7 of greater importance.

Slide 22 · HLA: A major susceptibility component in type 1 diabetes

HLA

Prominent, but not sufficient, genetic contribution

Certain HLA alleles account for more than half of the genetic risk in its description.

A strong locus contribution does not convert the disorder into a single-gene disease.

The broader inherited and environmental context still matters.

Slide 23 · Interpreting the type 1 diabetes example

The number of implicated genes is not their relative importance.

A small set of loci may account for a disproportionate share of susceptibility.

Type 1 diabetes remains an example of complex, multifactorial risk.

Slide 24 · Autoimmune diseases may share risk loci

Shared signal

Points toward overlapping susceptibility

Can motivate mechanistic investigation

Disease-specific signal

May help explain distinct manifestations

Does not itself establish diagnosis

Related immune-mediated conditions can share susceptibility polymorphisms.

Some risk loci are disease-specific, preserving differences between disorders.

Slide 25 · Atherosclerosis as a complex disorder

Atherosclerosis among common diseases with complex genetic susceptibility.

The multigenic model accommodates many inherited contributors rather than a single obligate lesion.

Environmental and other non-genetic influences remain relevant.

Slide 26 · Hypertension as a complex disorder

Inherited variant combinations

Environmental influences

Phenotype / disease susceptibility

Blood pressure is influenced by inherited variation and environmental factors.

A continuous blood-pressure phenotype can underlie a clinically defined disorder.

A single common allele generally does not provide a deterministic prediction.

Slide 27 · Type 2 diabetes illustrates modifiable risk

Inherited susceptibility

Polygenic predisposition

Not independently deterministic

Behavioral influences

Diet

Physical activity

Potential change in risk

Type 2 diabetes has many features of multifactorial inheritance.

Substantial genetic contributions together with diet and exercise.

Slide 28 · Cancers: Distinguish predisposition from tumor genetics

Inherited susceptibility

Present in germline background

May affect probability of developing cancer

Somatic tumor alterations

Acquired in a cell lineage

May drive tumor formation or progression

Cancers among disorders that can have complex inherited susceptibility.

Inherited polygenic risk is conceptually separate from mutations acquired in the tumor.

Slide 29 · Disease examples do not share a single mechanism

Example

Role in this lecture

Atherosclerosis

Multifactorial disease susceptibility

Type 1 diabetes

Unequal genetic-locus effects

Type 2 diabetes

Interaction with diet and exercise

Autoimmune disease

Shared and specific susceptibility variants

Atherosclerosis, diabetes, hypertension, autoimmune diseases, and some cancers are cited as complex conditions.

Slide 30 · Complex inheritance also governs normal traits

Multifactorial inheritance is not limited to pathological conditions.

Pigmentation, height, weight, blood pressure, and blood analytes.

These examples clarify how genetic and environmental contributions vary across a population.

Slide 31 · Examples of quantitative phenotypes

Trait

Interpretive point

Height

Nutritional environment can modify expression

Blood pressure

Continuous phenotype with clinical relevance

Weight

Multiple contributors

Blood analytes

Population variability

Height, weight, blood pressure, and blood analytes can vary continuously.

Slide 32 · Continuous variation differs from Mendelian categories

Lower observed values

Higher observed values

Qualitative illustration — not measured data

Quantitative traits may vary across a continuous range in a population.

A simple affected/unaffected pedigree may lose information about this variation.

Slide 33 · Bell-shaped population distributions

Lower observed values

Higher observed values

Qualitative illustration — not measured data

Some quantitative traits produce bell-shaped curves.

A bell shape summarizes many measured values near the center and fewer at extremes.

Slide 34 · A phenotype reflects more than sequence

Inherited variant combinations

Environmental influences

Phenotype / disease susceptibility

A genotype contributes to potential phenotype, but expression can be environmentally modified.

Two people with similar inherited susceptibility need not have identical measured traits.

Environment does not erase the underlying hereditary component.

Slide 35 · Nutrition can alter adult height

Shared inherited genetic background (monozygotic twins)

Nutritional environment A

Nutritional environment B

Possible different attained height

Growth differences between monozygotic twins to illustrate environmental effects.

Matching genomes do not guarantee equal attained height in different nutritional circumstances.

The example separates genetic identity from phenotypic identity.

Slide 36 · Monozygotic twins illustrate a key limit

Shared genetic background does not imply identical exposure.

Differences in nutrition can affect the expression of growth-related traits.

Twin similarity or difference should be interpreted in both genetic and environmental contexts.

Slide 37 · Diet and exercise in type 2 diabetes

Inherited variant combinations

Environmental influences

Phenotype / disease susceptibility

A substantial genetic contribution does not preclude preventive or risk-modifying behavior.

Diet and physical activity are the modifying factors specifically identified.

The textbook section does not supply effect sizes or a standardized intervention regimen.

Slide 38 · Genetic risk and modifiable risk are compatible

Invalid inference

“This allele means disease is inevitable.”

“Inherited predisposition nullifies prevention.”

Defensible interpretation

“This allele may alter susceptibility.”

“Environmental changes can matter.”

“Genetic” is not synonymous with “unmodifiable clinical outcome.”

The environmental component of multifactorial disease creates opportunities for changing risk.

Slide 39 · Why severity alone is an unreliable clue

A range of disease severity is compatible with complex multigenic inheritance.

However, monogenic conditions may also vary in expression or penetrance.

Clinical heterogeneity is suggestive but not diagnostic of a multigenic mechanism.

Slide 40 · Variable expressivity can mimic complexity

Same primary mutation

Monogenic etiology may remain present

Shared principal genetic defect

Different expression

Variable manifestations

Different degrees of severity

Variable expressivity: Individuals with a disease-associated genotype can show different manifestations.

This phenomenon may occur in single-gene disorders.

Slide 41 · Reduced penetrance can mimic sporadic occurrence

A person can carry a disease-associated monogenic variant without manifesting disease.

A pedigree may therefore look less clearly Mendelian than the underlying etiology.

Absence of disease in a carrier is not proof of polygenic inheritance.

Slide 42 · Do not assign inheritance mode from appearance

Insufficient evidence

Severity range alone

Sporadic clinical presentation alone

Appropriate evidence

Segregation context

Association across multiple loci

Supporting genetic studies

Multiple levels of clinical severity can arise from different etiologic architectures.

Assess inheritance evidence rather than assuming multigenicity from variability.

Slide 43 · Mendelian versus complex: Core contrasts

Feature

Monogenic

Complex multigenic

Genetic architecture

Principal single-gene defect

Multiple susceptibility loci

Typical variant effect

Often large

Often small

Inheritance

May be Mendelian

Non-Mendelian / multifactorial

Risk prediction

May be strong

Usually limited per locus

Monogenic disorders often involve one mutation of large functional impact.

Slide 44 · Why genome-wide association studies are used

Patients

Controls

Genome-wide comparison

Associated loci

GWAS compare genetic variation between affected patients and controls.

They test whether genetic markers occur with different frequency across groups.

Their objective is to locate susceptibility regions for complex disease.

Slide 45 · Case–control comparison is the design principle

Cases

Individuals with the phenotype

Genotyped at many loci

Controls

Individuals without the phenotype

Compared at the same loci

GWAS involving hundreds or thousands of cases and controls.

A detected association indicates a statistical relationship between a marker and disease status.

Slide 46 · GWAS identifies loci, not a diagnostic genotype

GWAS comparison

Risk-associated haplotype

Candidate genetic locus

Follow-up mechanism work

Association peaks highlight candidate genomic regions.

Each associated risk haplotype typically contributes a small change in disease odds.

The result requires interpretation in a multigenic and environmental framework.

Slide 47 · An odds ratio is not an individual outcome

Group association

Comparative disease odds

Population-based estimate

Patient-level prediction

Requires useful discrimination

Not guaranteed by statistical significance

Odds ratios describe an association in groups.

A modest odds ratio should not be interpreted as a high-penetrance mutation.

Slide 48 · Different loci may have different effect sizes

Complex disorders combine major susceptibility regions and many modest contributors.

Large-effect and small-effect loci should not be assumed equally predictive.

The type 1 diabetes/HLA example shows this asymmetry.

Slide 49 · GWAS candidate genes suggest mechanisms

Associated region

Candidate gene(s)

Mechanistic hypothesis

Further validation

Associated loci can direct investigation toward genes and biological pathways.

The value may be mechanistic even if immediate clinical utility is limited.

A locus hypothesis must still be distinguished from experimentally validated causation.

Slide 50 · What GWAS cannot establish alone

A marker–disease association does not identify the functional variant automatically.

It does not prove how the variant changes cellular physiology.

It does not establish clinical screening performance or patient-management benefit.

Slide 51 · A statistically robust finding may be clinically weak

Scientific discovery

Find associated genomic regions

Prioritize candidate pathways

Clinical translation

Predict an individual outcome

Change management

Requires further validation

A susceptibility signal can be informative for disease biology.

The same small-effect signal may be unhelpful when evaluating one patient.

Slide 52 · Interpreting a GWAS report step by step

Study phenotype

Associated marker

Effect interpretation

Clinical relevance

Identify the studied disease phenotype and the cases/controls.

Distinguish an associated marker or haplotype from the causal allele.

Examine the magnitude—not only statistical significance—of the association.

Ask whether a patient-care application has been separately validated.

Slide 53 · GWAS is not equivalent to genetic diagnosis

Mendelian molecular result

May identify a pathogenic familial variant

Can have high phenotypic impact

Common GWAS risk signal

Usually one of many small contributors

Limited standalone clinical value

A high-penetrance familial mutation may directly support molecular diagnosis in a defined context.

An individual small-effect GWAS haplotype usually estimates susceptibility only.

Slide 54 · Case discussion: Type 2 diabetes risk

Hypothetical patient: Several relatives have type 2 diabetes, but the patient currently has no diagnosis.

Can a family history establish that one particular susceptibility allele determines outcome?

What role might diet and physical activity play?

Slide 55 · Case discussion: Shared autoimmune susceptibility

Hypothetical observation: Two autoimmune disorders show association at some of the same polymorphic loci.

Does this imply the disorders are the same disease?

What might shared and disease-specific associations reveal?

Slide 56 · Case discussion: Variable clinical severity

Hypothetical pedigree: Affected relatives show a broad spectrum of symptoms.

Is the family necessarily affected by a polygenic disorder?

Which monogenic phenomena must remain in the differential explanation?

Slide 57 · Case discussion: GWAS association

A published case–control GWAS identifies an associated haplotype with a small effect on disease odds.

Can this marker establish disease in a healthy individual?

What is a defensible next scientific step?

Slide 58 · An integrated approach to complex traits

Define phenotype

Inherited architecture

Environmental context

Evidence-informed interpretation

First define the phenotype carefully and recognize whether it varies continuously.

Then consider the combined architecture of inherited susceptibility and environmental context.

Interpret association studies mechanistically without exaggerating individual prediction.

Slide 59 · Essential distinctions to retain

Polymorphism denotes population frequency, not necessarily pathogenicity.

Multigenic susceptibility does not equal an inevitable clinical outcome.

Variable expressivity or reduced penetrance can also occur in single-gene disease.

GWAS is valuable for mapping susceptibility, but often weak for individual management.

Slide 60 · Reference and source boundaries

Robbins, Cotran & Kumar: Pathologic Basis of Disease, 11th ed. (2026).

Chapter 5: Genes and Human Diseases; Complex Multigenic Disorders, printed pp. 143–144.

Additional parent-chapter context: overview of complex multigenic disorders, printed p. 123.

Figures and comparative diagrams in this lecture are original editable conceptual schematics, not clinical evidence.